Delivery Order SPE2DB22D2206-SPE2DB25FJB91
Award Date 7/25/25
Potential Completion Date 8/15/25
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $31,830.84 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This firm fixed-price delivery order, with completion targeted for September 4, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,305.14 to AmerisourceBergen Drug Corp for Imfinzi 500 mg/10 mL vials on July 31, 2025. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025....
- This delivery order, awarded on July 31, 2025, to AmerisourceBergen Drug Corp represents a $1,903.44 firm fixed-price contract for IMFINZI 120 mg/2.4 ml vials to be delivered by August 21, 2025. The contract was funded by the Defense Logistics Agency (DLA), the Department of Defense's supply and logistics arm, with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award, indicating it was...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $23,873.13 for IMFINZI 500 mg/10 mL vials under a firm fixed-price contract with the Defense Department's Medical Supply Chain. The award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. IMFINZI is a prescription oncology medication, and this order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,535,133 units of IMFINZI 500 MG/10 ML VIAL 10ML. The contract has a completion date of February 26, 2024 and a potential value of $15,420.00. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,262.85, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of July 14, 2025. The contract is a Firm Fixed Price agreement and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4563472635 - IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The contract, with a potential value of $38,550.00, has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor, delivering these specialty pharmaceutical supplies...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,830.84 delivery order is for IMFINZI 500 MG/10 ML VIAL 10ML, a type of medical supply. The contract has an ultimate completion date of July 16, 2025 and is a firm fixed-price agreement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,952.92 firm fixed-price delivery order contract is for the supply of IMFINZI 500 mg/10 ml vials, a specialty oncology medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...